Literature DB >> 31498507

Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.

Tomoya Kon1,2, Masahiko Tomiyama2, Koichi Wakabayashi1.   

Abstract

Lewy body disease (LBD) is characterized by the presence of Lewy bodies (LBs) and Lewy neurites and comprises a diagnostic spectrum that includes Parkinson's disease (PD), PD with dementia, and dementia with LBs. LBs and Lewy neurites are insoluble aggregates composed mainly of phosphorylated α-synuclein and can be widely distributed throughout the central and peripheral nervous systems. The distribution of LBs may determine the LBD phenotype. Braak hypothesized that Lewy pathology progresses ascendingly from the peripheral nervous system to the olfactory bulbs and brainstem and then to other brain regions. Braak's PD staging suggests that LBD is a prion-like disease. Most typical PD cases fit with Braak's PD staging, but the scheme fails in some cases. Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, multiple system atrophy, frontotemporal lobar degeneration, Creutzfeldt-Jakob disease, cerebrovascular diseases, and essential tremor are common misdiagnoses for pathologically confirmed LBD. LBD exhibits considerable heterogeneity in both clinical and pathological settings, which makes clinical diagnosis challenging.
© 2019 Japanese Society of Neuropathology.

Entities:  

Keywords:  Braak staging; Lewy body; Parkinson's disease; dementia; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31498507     DOI: 10.1111/neup.12597

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  13 in total

1.  Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.

Authors:  Peter T Nelson; Carol Brayne; Margaret E Flanagan; Erin L Abner; Sonal Agrawal; Johannes Attems; Rudolph J Castellani; Maria M Corrada; Matthew D Cykowski; Jing Di; Dennis W Dickson; Brittany N Dugger; John F Ervin; Jane Fleming; Jonathan Graff-Radford; Lea T Grinberg; Suvi R K Hokkanen; Sally Hunter; Alifiya Kapasi; Claudia H Kawas; Hannah A D Keage; C Dirk Keene; Mia Kero; David S Knopman; Naomi Kouri; Gabor G Kovacs; Sydney A Labuzan; Eric B Larson; Caitlin S Latimer; Renata E P Leite; Billie J Matchett; Fiona E Matthews; Richard Merrick; Thomas J Montine; Melissa E Murray; Liisa Myllykangas; Sukriti Nag; Ruth S Nelson; Janna H Neltner; Aivi T Nguyen; Ronald C Petersen; Tuomo Polvikoski; R Ross Reichard; Roberta D Rodriguez; Claudia K Suemoto; Shih-Hsiu J Wang; Stephen B Wharton; Lon White; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2022-06-13       Impact factor: 15.887

Review 2.  Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.

Authors:  Rotem Iris Orad; Tamara Shiner
Journal:  J Neurol       Date:  2021-01-29       Impact factor: 4.849

Review 3.  Neuropathology and molecular diagnosis of Synucleinopathies.

Authors:  Shunsuke Koga; Hiroaki Sekiya; Naveen Kondru; Owen A Ross; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2021-12-18       Impact factor: 14.195

4.  Colonic Leucine-Rich Repeat Kinase 2 Expression Is Increased and Associated With Disease Severity in Patients With Parkinson's Disease.

Authors:  Peng-Hsiang Liao; Han-Lin Chiang; Chia-Tung Shun; Jen-Fan Hang; Han-Mo Chiu; Ming-Shiang Wu; Chin-Hsien Lin
Journal:  Front Aging Neurosci       Date:  2022-01-17       Impact factor: 5.750

5.  Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology.

Authors:  Jagan A Pillai; James Bena; Kasia Rothenberg; Bryce Boron; James B Leverenz
Journal:  JAMA Netw Open       Date:  2022-03-01

6.  Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model.

Authors:  Davide Cenci; Manuel Glauco Carbone; Camilla Callegari; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

7.  Autopsy Validation of the Diagnostic Accuracy of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease.

Authors:  Tomoyasu Matsubara; Masashi Kameyama; Noriko Tanaka; Renpei Sengoku; Makoto Orita; Ko Furuta; Atsushi Iwata; Tomio Arai; Hirofumi Maruyama; Yuko Saito; Shigeo Murayama
Journal:  Neurology       Date:  2022-03-07       Impact factor: 9.910

Review 8.  Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson's Disease.

Authors:  Sean J Miller; Cameron E Campbell; Helen A Jimenez-Corea; Guan-Hui Wu; Robert Logan
Journal:  Front Neurosci       Date:  2022-04-19       Impact factor: 5.152

9.  Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases.

Authors:  Zen-Ichi Tanei; Yuko Saito; Shinji Ito; Tomoyasu Matsubara; Atsuko Motoda; Mikihiro Yamazaki; Yasuhiro Sakashita; Ito Kawakami; Masako Ikemura; Shinya Tanaka; Renpei Sengoku; Tomio Arai; Shigeo Murayama
Journal:  Acta Neuropathol       Date:  2020-11-05       Impact factor: 17.088

10.  The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.

Authors:  Tim E Moors; Christina A Maat; Daniel Niedieker; Daniel Mona; Dennis Petersen; Evelien Timmermans-Huisman; Jeroen Kole; Samir F El-Mashtoly; Liz Spycher; Wagner Zago; Robin Barbour; Olaf Mundigl; Klaus Kaluza; Sylwia Huber; Melanie N Hug; Thomas Kremer; Mirko Ritter; Sebastian Dziadek; Jeroen J G Geurts; Klaus Gerwert; Markus Britschgi; Wilma D J van de Berg
Journal:  Acta Neuropathol       Date:  2021-06-11       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.